Current vaccine trials in glioblastoma: a review
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-04-03 / J Immunol Res 2014;2014:796856Novel approaches and mechanisms of immunotherapy for glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-03-01 / Discov Med 2014 Mar;17(93):145-54Natural killer cells: the secret weapon in dendritic cell vaccination strategies
/in Dendritic Cells, International Publications /von 2014-03-01 / Clin. Cancer Res. 2014 Mar;20(5):1095-103Phase I dendritic cell p53 peptide vaccine for head and neck cancer
/in Dendritic Cells, International Publications /von 2014-02-28 / Clin. Cancer Res. 2014 May;20(9):2433-44Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-02-27 / Oncoimmunology 2014 Jan;3(1):e27589Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-02-18 / J Immunother Cancer 2014;2:4Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-02-05 / Cancer Immunol Res 2014 May;2(5):404-9Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2014-01-13 / Hum Vaccin Immunother 2014;10(4):970-6Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
/in Dendritic Cells, International Publications /von 2014-01-03 / Cancer Immunol. Immunother. 2014 Apr;63(4):321-33IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de